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In this study, we investigated the inhibitory effects of ethanolic extract of the leaves of
Senna surattensis (EESS) on a-glucosidase and a-amylase. We also studied the in vitro
antidiabetic activity of S. surattensis using the glucose uptake by isolated rat hemidiaph-
ragm model. In vitro studies using mammalian a-glucosidase extracted from the small
intestine homogenate of mouse showed that the extract was found to be more effective
in inhibiting the activities of maltase [half maximal inhibitory concentration (IC50):
209.15 mg/mL] and sucrase (IC50: 366.44 mg/mL) when compared with the control group
(acarbose). The extract of S. surattensis were further quantified with respect to porcine
pancreatic a-amylase inhibition using the chromogenic 3,5-dinitrosalicylic acid method.
Interestingly, S. surattensis was also found to exhibit a-amylase (IC50: 123.95 mg/mL)
inhibitory activity. The glucose uptake in the rat hemidiaphragm was significantly
(p < 0.01) increased by EESS (220.95  5.4 mg/g/30 minute) when compared with the
control group. The total polyphenolic content of EESS was found to be 98 mg pyrocate-
chol/mg of the extract. These results suggest that EESS inhibited carbohydrate digestive
enzymes and increased the peripheral uptake of glucose. This study endorses the use of
this plant for further studies to determine their potential for managing type II diabetes.osy and Phytotherapy Research Laboratory, Division of Pharmacognosy, Department of Pharmaceu-
ering and Technology, Jadavpur University, Kolkata 700 032, India.
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Effects of S. surattensis extract on carbohydrate-hydrolyzing enzymes 251. Introduction with NIDDM [10,11]. Direct stimulation of basal glucose
transport, disposal, and metabolism in muscle and fat cellsNoninsulin-dependent diabetes mellitus (NIDDM) is
a common disease of the endocrine system caused by the
decreased secretion of insulin by the pancreatic Langerhans
b cell or by the lowering of insulin resistance due to
excessive absorption of glucose [1]. A number of pharma-
cological approaches are used to control diabetes by
different modes of action such as stimulation of insulin
release, increase in the number of glucose transporters,
inhibition of gluconeogenesis, and reducing absorption of
glucose from the intestine [2]. Diabetes is a multifactorial
disease leading to several complications and, therefore, it
demands multiple therapeutic approaches. In the predia-
betic state of insulin resistance, glycemic control can be
achieved using oral agents that either interfere with the
absorption of glucose (a-glycosidase and/or pancreatic a-
amylase inhibitors) or facilitate glucose disposal in periph-
eral tissues (insulin-sensitizing agents). One of the most
beneficial therapies for NIDDM is said to be the control of
postprandial hyperglycemia after a meal [3]. In patients
with diabetes, postprandial hyperglycemia is most
pronounced following a meal due to the absorption of
glucose from the gastrointestinal tract. Inhibiting glucose
uptake in the intestines and/or promoting glucose disposal
in the tissues may be beneficial for these patients to control
the blood glucose level in the postprandial state.
Acting as a key enzyme for carbohydrate digestion is
intestinal a-glucosidase, a glucosidase secreted in the
epithelium of the small intestine. a-Glucosidase has been
recognized as a therapeutic target for the modulation of
postprandial hyperglycemia, which is the earliest metabolic
abnormality that occurs in NIDDM [4]. The major source of
blood glucose is dietary carbohydrates such as starch,
which are hydrolyzed by a-glucosidases and pancreatic a-
amylase, so as to be absorbed by the small intestine.
Therefore, an effective treatment option for NIDDM is to
inhibit the activity of a-glucosidases and pancreatic
a-amylase [5]. In this regard, inhibitors can retard the
uptake of dietary carbohydrates, suppress postprandial
hyperglycemia, and could be useful for treating patients
with diabetes and/or obesity [6]. a-Glucosidase inhibitors
such as acarbose, miglitol, and voglibose are known to
reduce postprandial hyperglycemia primarily by interfering
with the activity of carbohydrate-digesting enzymes and
delaying glucose absorption. In addition, numerous a-
glucosidase inhibitors have been extracted from plants,
which are of clinical importance [7,8].
Diabetes mellitus is also characterized by a diminished
reaction of insulin-sensitive peripheral tissues and
a marked decrease in glucose uptake and metabolism in
response to insulin. The defective glucose transport system
may play an important role in the pathogenesis of periph-
eral insulin resistance, and glucose uptake in target tissues
is a critical step in maintaining glucose homeostasis and in
clearing the postprandial glucose load [9]. To enhance the
glucose uptake by peripheral cells, biguanides such as
metformin are used to control postprandial hyperglycemia
in patients with NIDDM. This has been attributed to
increased glucose disposal by peripheral tissues, as
observed in euglycemic clamp studies in rats and patientswould explain increased glucose utilization. Therefore,
cellular assays are used to determine the mechanism of
action of natural or synthetic compounds from isolated rat
diaphragms, as well as isolated and cultured rat 3T3
adipocytes. For this reason, it is highly desirable to find new
antidiabetic agents from natural resources that stimulate
glucose uptake/disposal by peripheral tissues such as
adipose tissue or muscle cells.
Recent interests in the study of plant polyphenols have
focused on their potential benefits to human health. The
polyphenols are capable not only of reducing oxidative
stress but also of inhibiting carbohydrate-hydrolyzing
enzymes to prevent hyperglycemia [12,13]. Senna sur-
attensis Burm. f./Cassia surattensis Burm. f. (syn: C.
glauca Lam., Family: Caesalpiniaceae) is commonly known
as Glaucous cassia. It is a small tree or a large shrub,
distributed throughout India. The tender leaves are
consumed as a vegetable with rice [14]. Bark and leaves are
useful for treating diabetes and gonorrhea, and the aerial
parts are used for treating diabetes [15,16]. The plant is
described as a medication for diabetes, gonorrhea, and
blennorrhea [17]. The beads made from its wood are worn
around the neck to cure jaundice [18]. A phytoconstituent
reported in this plant contains anthraquinone, flavonol
glycosides, chrysophanol, kaempferol, and quercetin
[19e21]. This plant has been used as traditional medicine
for the treatment of diabetes, but scientific evaluation is
still lacking in this regard. To clarify its mechanism of
action, we evaluated the inhibitory effect of ethanolic
extract of S. surattensis (EESS) on postprandial blood
glucose levels in vitro. Therefore, this study was aimed at
establishing the potential therapeutic value of EESS by
evaluating its in vitro inhibitory activities against a-gluco-
sidase, a-amylase, and by calculating the glucose uptake by
the isolated rat hemidiaphragm.2. Materials and methods2.1. Plant materials
Fresh leaves of S. surattensis were collected from Tiruchir-
appalli (Tamil Nadu, India) in December 2006 and authenti-
cated by the Botanical Survey of India (Coimbatore, Tamil
Nadu, India; Ref. No.: BSI/SC/5/23/06-07/Tech-1638). An
authentic voucher specimenwas deposited in the Herbarium
of Division of Pharmacognosy, Department of Pharmaceu-
tical Technology, Jadavpur University, Kolkata, India.2.2. Preparation of plant extract
The collected leaves were air dried at room temperature
without exposure to sunlight, coarsely powdered (300 g),
and then extracted with ethanol (95%) in a Soxhlet appa-
ratus. The solvent was then evaporated under reduced
pressure in a rotary evaporator (Superfit, India) at <40C to
obtain a dry extract (yield 24.25% w/w) that was stored
at e20C in a refrigerator until further use.
26 E. Thilagam et al.2.3. Preliminary phytochemical analysis
The EESS was subjected to preliminary phytochemical
analysis to detect the composition of the phytoconstituent
using standard chemical tests [22].
2.4. Estimation of total phenol content
The total phenolic content of EESS was determined using
FolineCiocalteu reagent [23]. In brief, the analysis is
carried out as follows: 1 mL of extract solution containing
1 mg of extract was transferred into 100-mL Erlenmeyer
flask and then the final volume was adjusted to 46 mL by
adding distilled water. To this mixture, 1 mL of
FolineCiocalteu reagent was added and after 3 minutes,
3 mL of Na2CO3 (2%) was also added. Subsequently, the
mixture was shaken on a shaker for 2 hours at room
temperature and then its absorbance was measured at
760 nm. The concentration of the total phenolic content
was expressed as micrograms of pyrocatechol using an
equation that was obtained from standard pyrocatechol
graph. The equation used is as follows:
Absorbance Z 0.001  Pyrocatechol (mg) þ 0.0033.
2.5. Animal and ethical approval
Male and female Swiss albino rats and mice, weighing about
200e250 g and 20e25 g body weight, respectively, were
used in this study. The animals were collected from
a breeding colony and acclimatized to the laboratory
condition for 2 weeks. They were housed in makrolon cages
under standard laboratory conditions (light period: 7.00 AM
to 7.00 PM, temperature: 21  2C; and relative humidity
55e70%). The animals were fed with commercial diet
(Hindustan Lever Ltd., Bangalore, India) and had free
access to water (ad libitum) during the experiments. The
experiments conducted were in accordance with the rulings
of the Committee for the Purpose of Control and Supervi-
sion of Experiments on Animals, New Delhi, India (Regis-
tration No.: 0367/01/C/CPCSEA) and the study was
permitted by the Institutional Animal Ethical Committee of
the Jadavpur University, Kolkata, India.
2.6. a-Glucosidase inhibitory assay
This assay was carried out to investigate the in vitro
inhibitory activity of EESS on sucrase and maltase (a-
glucosidases). Although a-glucosidase isolated from yeast is
extensively used as a screening material for a-glucosidase
inhibitors, the results did not always agree with those ob-
tained in mammals. Therefore, we used a small intestine
homogenate of a mouse as a-glucosidase solution because
we speculated that it would better reflect the in vivo state.
The inhibitory effect was measured by slightly modifying
the method used by “Dahlqvist” [24]. After 20 hours of
fasting, part of the animals’ small intestine immediately
below the duodenum and immediately above the cecum
was cut, rinsed with ice-cold saline, and homogenized with
12 mL of maleate buffer (100 mM, pH 6). The homogenate
was used as a-glucosidase solution. The assay mixture
consisted of 100 mM maleate buffer (pH 6), 2% (w/v) ofeach sugar substrate solution (100 ml), and the sample
extract (20e640 mg/mL). The mixture was preincubated for
5 minutes at 37C, and the reaction was initiated by adding
crude a-glucosidase solution (50 ml), followed by incubating
the mixture again for 10 minutes at 37C. The amount of
glucose released in this reaction was determined by
a commercially available glucose estimation kit (Span
Diagnostic Ltd., Mumbai, India). The rate of carbohydrate
decomposition was calculated as a percentage ratio to the
amount of glucose obtained when the carbohydrate was
completely digested. The rate of prevention was calculated
by the following formula:
Inhibition rate (%)Z [{(amount of glucose producedby the
positive control) e (amount of glucose produced by the
addition of EESS) e (glucose production value in blank)/
(amount of glucose produced by the positive control)}] 100.
2.7. a-Amylase inhibitory assay
Test samples [EESS (6.25, 12.5, 25, 50, 100, 200 mg/mL) and
nojirimycin (6.25e200 mg/mL)] of 500 ml concentration were
added to 500 ml of 0.02 M sodium phosphate buffer (pH 6.9
with 0.006 M sodium chloride) containing 0.5 mg/mL porcine
pancreatic a-amylase solution (Sigma Chemical Co., St.
Louis, MO, USA) and were incubated at 25C for 10 minutes.
After the preincubation, 500 ml of 1% starch solution in 0.02 M
sodium phosphate buffer (pH 6.9 with 0.006 M sodium chlo-
ride) was added to each tube at prespecified intervals. The
reaction mixtures were then incubated at 25C for 10
minutes. The reaction was stopped by adding 1 mL of 3,5-
dinitrosalicylic acid color reagent. The test tubes were then
incubated in a boiling water bath for 5 minutes and cooled
down to room temperature. The reaction mixture was then
diluted after adding 10 mL of distilled water and absorbance
was measured at 540 nm [25].
% inhibition Z
Abscontrol ð540Þ  Absextract ð540Þ
Abscontrol ð540Þ
2.8. Glucose uptake by isolated rat hemidiaphragm
Glucose uptake by rat hemidiaphragm was estimated
according to earlier works [26,27], but with some modifi-
cations. Four groups, with each group containing six grad-
uated test tubes (n Z 6), were considered as follows:
Group 1: 2 mL of Tyrode solution with 2% glucose.
Group 2: 2 mL of Tyrode solution with 2% glucose and
regular insulin solution (Novo Nordisk; 0.62 mL of 0.4 U/
mL).
Group 3: 2 mL of Tyrode solution and 1.38 mL of EESS
(0.1% v/v).
Group 4: 2 mL of Tyrode solution with 2% glucose and
regular insulin (0.62 mL of 0.4 U/mL) solution and
1.38 mL of EESS (0.1% v/v)
The volumes of all the test tubes were made up to 4 mL
by adding distilled water to match the volume of the test
tubes in Group 4. A total of 12 albino rats were fasted
overnight and decapitated. The diaphragms were quickly
dissected with minimal trauma and divided into two halves.
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the same set of experiments. Six diaphragms were used for
each group. The hemidiaphragms were placed in test tubes
and incubated for 30 minutes at 37C in an atmosphere of
100% oxygen and were shaken at a speed of 140 cycles/
minute. Glucose uptake per gram of tissue was calculated
as the difference between the initial and final glucose
content in the incubated medium.
2.9. Statistical analysis
The experimental results were presented as
mean  standard error of the mean of three parallel
measurements. Statistical analysis was performed using
one-way analysis of variance. Significant differences
between means were determined by Duncan’s multiple
range tests. Values of p < 0.01 and p < 0.05 were consid-
ered to be statistically significant.
3. Results
3.1. Preliminary phytochemical analysis
Preliminary phytochemical analysis of EESS showed positive
results for steroids, triterpenoids, and flavonoids. The total
phenolic compounds of the ethanol extract were expressed
as micrograms of pyrocatechol (phenolic content: 98 mg
pyrocatechol/mg of extract) equivalent per milligram of S.
surattensis leaves extract. A chromatographic technique on
silica gel 60 with chloroform and methanol mixture as
mobile phase in a saturated chamber is used for the base-
line separation of the target compounds. The polyphenolic
profile of S. surattensis can be visualized using fast blue
salt B reagent. The major types of phenolic constituents
identified in the leaves of S. surattensis are simple phenolic
acids, flavonol, flavones, flavonones, and flavonoid glyco-
sides. Phytochemical analysis of S. surattensis extract has
shown the presence of the flavonoids quercetin, rutin, and
kaempferol, quercetin 3-O-glucoside-7-O-rhamnoside,
which are known for their antioxidant activities. Therefore,
the presence of these chemicals may be one of the reasons
why the EESS showed good in vitro antihyperglycemic
activity.
3.2. a-Glucosidase and a-amylase inhibitory
activities
In order to investigate the inhibitory effect of S. surattensis
extract, an in vitro a-glucosidase inhibition test was per-
formed. Although a-glucosidase isolated from yeast is
extensively used as a screening material for a-glucosidase
inhibitors, the results did not always agree with those ob-
tained in mammals. The half maximal inhibitory concen-
tration (IC50) values of maltase and sucrase inhibitory
activities were 209.15 and 366.44 mg/mL, respectively. The
results in Figs. 1 and 2 show that EESS exhibited strong
activity in a dose-dependent manner and is thus inferred to
be an effective a-glucosidase inhibitor. In this study, EESS
exhibited strong inhibitory activity against a-glucosidase
and a-amylase, which is comparable with positive controlsof acarbose and nojirimycin, respectively. In addition, EESS
inhibited the activity of a-amylase with IC50 of 123.95 mg/
mL, the result of which is shown in Fig. 3. However, EESS
showed weak a-glucosidase and a-amylase inhibitory
activities compared with acarbose and nojirimycin,
respectively. These results confirm that EESS have
a-glucosidase and a-amylase inhibitory properties.
3.3. Effect on peripheral glucose uptake
The estimation of glucose content in rat hemidiaphragm
was used for the in vitro study of peripheral uptake of
glucose. Table 1 shows glucose uptake (milligrams/gram
tissue weight) in an isolated rat hemidiaphragm muscle in
the presence of insulin (0.4 U/mL) and EESS (0.1% w/v). The
results of this experiment indicate that the addition of EESS
to the incubation media (Tyrode solution) caused significant
increase in glucose uptake by the rat hemidiaphragm
and was found to be less effective than insulin
(240.876  3.538). Moreover, EESS seemed to be more
effective in enhancing peripheral glucose uptake in rat
hemidiaphragm in the absence of insulin. Treatment with
EESS (0.1% w/v) also elicited a significant increase
(p < 0.01) in glucose uptake by the isolated rat hemi-
diaphragm (220.95  5.443) when compared with the
control groups (80.896  3.406). These results show that
treatment with insulin or EESS alone for 30 minutes
produced a significant increase in glucose uptake by 2.98-
and 2.73-fold, respectively; however, combined incubation
with both insulin and EESS exerted the rate by 2.28-fold, an
increase of glucose uptake in rat hemidiaphragm compared
with untreated control groups. The addition of both EESS
and insulin to the incubation media caused an increase of
insulin binding to the rat hemidiaphragm as compared with
the blank. The glucose uptake by rat hemidiaphragm was
significantly more in all the groups tested when compared
with the control group.
4. Discussion
Diabetes is characterized by high concentrations of blood
sugar levels, which can cause serious complications, such as
organ failures and/or destruction of the kidneys, eyes, and
various cardiovascular diseases. Therefore, the treatment
methodsmainly focus on reducing fluctuations in blood sugar
levels and their related complications. One of the thera-
peutic approaches is to decrease the postprandial hyper-
glycemia by retarding the absorption of glucose through the
inhibition of carbohydrate-hydrolyzing enzymes, such as
a-amylase and a-glucosidase [28,29]. a-Glucosidases are
enzymes that catalyze the absorption of digested glucose
from dietary polysaccharides in the small intestine.
The a-glucosidase inhibition of EESS was evaluated by
determining the a-glucosidase inhibitory activity using 4-
Nitrophenyl-b-D-glucopyranosiduronic acid (pNPG) as the
reaction substrate. The crude enzyme solution prepared from
a mouse’s small intestine was used as a source of a-glucosi-
dases, sucrase, maltase, and isomaltase. a-Glucosidase cata-
lyzes the final step in the digestion of carbohydrates and its
inhibitors can retard the uptake of dietary carbohydrates and
suppress postprandial hyperglycemia, which can be a useful
Figure 1 a-Glucosidase (sucrase) inhibitory activity of ethanolic extract of Senna surattensis (EESS). The values presented are
expressed as mean  standard error of the mean of triplicate experiments.
28 E. Thilagam et al.mechanism in the preparation of antidiabetic drugs [30].
However, it is unclear whether the mechanism of inhibition of
a-amylase and a-glucosidase by EESS is due to competitive and
noncompetitive method. The fact that a-amylase and a-
glucosidase showed different inhibition kinetics seemed to be
due to structural differences related to the origins of the
enzymes [31]. However, the inhibition rate for a-glucosidase
was close to that of acarbose, and the inhibition rate for a-
amylase was obviously lower than that of acarbose. ThisFigure 2 a-Glucosidase (maltase) inhibitory activity of ethanolic
expressed as mean  standard error of the mean of triplicate expindicated that EESS was a strong inhibitor for a-glucosidase
with mild inhibitory activity against a-amylase. The inhibition
of a-glucosidase, together with a-amylase by EESS, is consid-
ered to be an effective strategy for the control of diabetes by
diminishing the absorption of glucose [32].
Severe postprandial hyperglycemia commonly experi-
enced by patients with diabetes could be prevented if the
rate of glucose uptake from the intestine into the circula-
tion could be reduced by inhibiting carbohydrate digestionextract of Senna surattensis (EESS). The values presented are
eriments.
Figure 3 a-Maylase inhibitory activity of ethanolic extract of Senna surattensis (EESS). The values presented are expressed as
mean  standard error of the mean of triplicate experiments.
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total body weight and seems to be one of the most
important target tissues for the action of insulin and for the
uptake of glucose at the peripheral level [33]. It is a well-
known fact that insulin and antidiabetic drugs promote
glucose uptake by peripheral cells and tissues [34]. Another
important finding of this work is that EESS possesses
considerable insulin-like properties, as evidenced by the
enhancement of glucose uptake in the diaphragm, which
represents muscle cells that are a major site of insulin-
medicated glucose disposal. Pieces of hemidiaphragm
were incubated with different concentrations of EESS and
insulin for 30 minutes. The estimation of glucose content in
rat hemidiaphragm is a commonly used and a reliable
method for the in vitro study of peripheral uptake of
glucose. In addition, EESS significantly enhances the uptake
of glucose by isolated hemidiaphragm and is found to be
less effective than insulin. It appears that EESS has direct
peripheral action. The control value of glucose uptake by
rat hemidiaphragm corresponds with those of earlier find-
ings [27]. Uptake of glucose by the rat abdominal muscle
(milligrams/gram tissue weight) was calculated as the
clearing of glucose from the perfusion medium. Therefore,Table 1 Effect of EESS on glucose uptake by isolated rat
hemidiaphragm.
Group Glucose uptake (mg/g/30 min)
Control 80.896  3.406
Insulin 240.876  3.538*
EESS 220.95  5.443*
EESS þ insulin 184.94  4.988*
Values are mean  standard error of the mean (n Z 6).
* p < 0.01 as compared with control.
EESS Z ethanolic extract of the leaves of Senna surattensis.EESS acts directly on the uptake of glucose at the periph-
eral levels, either alone or as an insulin coadjuvant.
Apreliminary phytochemical analysis of EESS revealed the
presence of polyphenols, flavonoids, flavonol, and flavonol
glycosides, including rutin, quercetin, and kaempferol
[35,36]. Polyphenolic compounds in plants have been shown
to inhibit the activities of digestive enzymes due to their
ability to bindwith proteins [37]. Polyphenolic compounds of
EESS may interfere with the activity of digestive enzymes in
the brush border of the small intestine, could slow the
liberation of D-glucose from oligosaccharide and disaccha-
rides, resulting in delayed glucose absorption and decreasing
postprandial glucose levels. Results froma number of studies
suggest that these phenolic compounds isolated from a large
number of medicinal plants [38,39] could have potential to
treat Type II diabetes mellitus.
Polyphenols are a complex group of chemicals that are
widely distributed throughout the plant kingdom and thus
form an integral part of the human diet. Therefore, the
inhibition of a-glucosidase found in our experiments could
be due to the presence of polyphenolic compounds.
Phenolic phytochemicals from EESS may potentially provide
a natural source of a-glucosidase inhibitors. These poly-
phenolic compounds have been found to be responsible for
blood glucose lowering activity and have also been reported
to activate GLUT1-mediated glucose uptake [40,41]. Inhi-
bition of carbohydrate digestive enzymes (a-glucosidase
and a-amylase) and enhanced peripheral uptake of glucose
by hemidiaphragm are the possible preliminary mechanisms
involved in its hypoglycemic activity. Further investigation
is needed to determine the individual polyphenol compo-
nents present in S. surattensis that may be responsible for
improvements in health conditions by regulating a-gluco-
sidase and a-amylase inhibitory activities. Isolation of the
active components is currently being pursued in our labo-
ratory to better understand the mechanism of enzyme
inhibition.
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